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ALAN CLAYTON-MATTHEWS
We benefit from medical devices throughout our lives: Prenatal development is monitored by ultrasound devices,
sports injuries are diagnosed with magnetic resonance imaging and fixed with arthroscopic tools, and heart
blockages are cleared with angioplasties and drug-coated stents. Devices include the simple and mundane—
eyeglasses and thermometers—and stretch to the boundaries of technology—laser scalpels, needles embedded with
microprocessors, MRI machines, and artificial hearts. All are products of the medical device industry. Massa-
chusetts is one of the nation’s leading states in medical device development and production.
Medical Devices
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Medical devices have drastically reduced the in-vasiveness of surgical procedures, shortenedrecovery times, and lowered medical costs. This
trend is continuing at a rapid pace, aided by advances in
electronics and biotechnology. To aid diabetics, for example,
internal pumps under development will monitor and de-
liver insulin; they are the closest thing yet to an artificial
pancreas. Medical devices and biotechnology developments
are becoming increasingly complementary over time, as de-
vices of increasing sophistication and miniaturization are
used to deliver new pharmaceutical and biotechnological
products. In the future, “nano” may be used to deliver bio-
logical agents directly to cancer cells.
The field of medical devices is the larger part of a medi-
cal science sector that supports the health services sector.
According to statistics from the 1997 Economic Census,1
the medical science sector in Massachusetts was composed
of three industry groups:
• the medical device industry, which consisted of 264 manu-
facturing establishments with 20,756 employees, a pay-
roll of $989 million, and shipments of $4.0 billion;
• pharmaceuticals, which consisted of 57 manufacturing es-
tablishments with 5,612 employees, a payroll of $270
million, and shipments of $1.8 billion; and
• biotechnology, which consisted of 282 research estab-
lishments with 9,311 employees, a payroll of $589 mil-
lion, and shipments of $1.5 billion.
Altogether, the Commonwealth’s medical science sector con-
sisted of 603 establishments with 35,679 workers, a payroll of
over $1.8 billion, and shipments of $7.3 billion. This sector is
therefore larger than several key high-technology sectors, in-
cluding computers and office equipment, and electronic com-


































































Massachusetts Medical Devices in a National Context
Using four measures of economic size and impact from the
1997 Economic Census—value of shipments, employment,
payroll, and value added (labor plus overhead)—expressed
in both absolute size and per capita terms, Minnesota and
Massachusetts lead the nation in the production of medical
devices. Though Massachusetts does not rank first on any
of the eight criteria, it ranks high on all.
In terms of population and overall economic activity,
California, Illinois, New York, and Florida are far larger than
either Massachusetts or Minnesota, so their higher rankings
on measures of absolute size do not indicate a higher con-
centration of medical device manufacturing. To rank states
in terms of concentration of medical device activity, per
capita comparisons are appropriate.
One way to com-
bine these ranking crite-
ria into a single com-
parison measure is to
assign a rank score to
each and form states’ to-
tal scores as the sum of
their rank scores on each
category.2  Using this
simple scheme, Minne-
sota and Massachusetts
rank first and second, re-
spectively, on the four
per capita measures and




























Source: U.S. Bureau of the Census, 1997 Economic Census
Rankings of Top Five Medical Device States
by Production Characteristic
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Combining all eight criteria, Massachusetts ranks second
behind Minnesota and ahead of California, Illinois, Con-
necticut, and Utah. The thrust of these rankings is con-
firmed by conversations with industry executives in the
Commonwealth. Minnesota and Massachusetts have simi-
lar agglomeration economies, with a favorable mix of higher
education, as well as medical and high-tech industries.
Why be concerned about how Massachusetts ranks in
measures of medical device production relative to other
states? The one-word answer is “exports.” Over half the
output of the Commonwealth’s medical device industry is
exported to other states or countries.3  Because revenues
from exports are ultimately received by Massachusetts work-
ers and suppliers of capital to the state’s medical device com-
panies, industries that export support the state economy’s
health and growth. Given the agglomeration economies that
are favorable to production of medical devices—that is, the
state’s concentration in higher education, teaching hospi-
tals, precision production, and electronics—Massachusetts
would be expected to rank high on measures of relative
production volume, and it does.
Basic Characteristics of the Massachusetts and
U.S. Medical Device Industry
Number and size of establishments. According to the
1997 Economic Census, there were 264 manufacturing es-
tablishments in the state’s medical device industry. These
companies employed 20,800 workers, or 3.39 of every thou-
sand residents. Nationally, there were 335,800 employees
in 1997, or 1.26 per thousand residents. The industry is
thus 2.7 times as concentrated in Massachusetts as in the
nation overall. The value of shipments from the state’s manu-
facturing facilities totaled $4.0 billion, with a payroll in 1997
of $1.0 billion.
Aggregate sales are dominated by a handful of large
companies. In a 2000 Boston Business Journal survey of
the largest 25 medical device employers in Massachusetts,
1999 sales ranged from $2.8 billion for Boston Scientific
Corporation, the largest company, to $2.5 million for
UroMed Corporation, the 24th-ranked company in terms
of sales.
As of 1998, there were just over two dozen Massachu-
setts-headquartered, publicly held medical companies, with
$3.2 billion in sales. Though the vast majority of compa-
nies are privately held and small by comparison (approxi-
mately half these manufacturing establishments were small,
employing fewer than 20 employees), they are critically im-
portant to the vitality and technological advancement of
this industry. One indicator is the scale of venture capital
funding, which is targeted to small start-ups. Over the four
quarters ending in the third quarter of 2000, venture capi-
tal funding received by the state’s medical device firms to-
taled $314 million.4  To illustrate its magnitude, this invest-
ment is roughly equal to the total research and develop-
ment spending of the 26 Massachusetts-headquartered, pub-
licly held medical device companies in 1997 and is nearly
twice the amount spent in 1997 on capital expenditures for
all medical device manufacturing establishments in the state.
Industrial composition. In Massachusetts, surgical and
medical instruments is the largest industry in the medical
device sector, with 37 percent of medical device employ-
ment. The next largest, with 23 percent of employment, is
electromedical and electrotherapeutic apparatuses. In con-
trast, these two industries comprise 31 percent and 16 per-
cent of national medical device employment, respectively.
The relative concentration of these two industries in Mas-
sachusetts reflects the state’s comparative specialization in
precision specialty production and electronics.
The distribution of employment in Massachusetts
among the other medical device industries is 11 percent in
surgical appliances and supplies, 9 percent in irradiation
Massachusetts Annual Wages in
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apparatuses, 9 percent in ophthalmic goods, 7 percent in
in-vitro diagnostic substances, and 4 percent in laboratory
apparatuses and furniture. Relative to the nation as a whole,
Massachusetts has a higher proportion of its employment in
irradiation apparatuses and a lower proportion in surgical
appliances and supplies and in-vitro diagnostic substances.
Employment wages, salaries, and benefits. Not sur-
prisingly, wages and salaries in medical devices are higher
than in manufacturing and in the economy as a whole. Me-
dian annual wages of medical device workers were $30,000
during 1994–1998, according to the CPS, versus $28,000
in manufacturing and $21,243 for all workers.5
Even though manufacturing workers on the whole have
a lower level of education than all workers, they are gener-
ally paid better, which is true at every level of educational
attainment. For college-educated medical device workers,
this premium is even greater. A medical device worker with
an associate’s degree earned an average annual salary of
$41,145 in 1994–1998, versus $36,916 in all manufactur-
ing and $30,470 in all jobs. A medical device worker with a
bachelor’s degree earned, on average, $66,292 per year ver-
sus $54,012 in all manufacturing and $44,307 in all jobs; a
medical device worker with a professional or graduate de-
gree earned an average of $85,101 per year versus $77,477
in all manufacturing and $70,704 in all jobs. These premi-
ums probably reflect the value of specific job training for
those with a high school education or less and higher mar-
ket valuations for degrees related to medical device research
and development for those with a college education. One
in 20 medical device workers earned more than $100,000
annually in the1994–1998 period.
Current and Future Trends
The Commonwealth’s medical device industry is expand-
ing rapidly. Employment, wages, productivity, and foreign
exports have grown faster than the state’s manufacturing
sector as a whole, and medical device wages and foreign
exports have been growing faster in Massachusetts than in
the nation.
Employment. Since 1993, medical device employment
in Massachusetts has been up and down, but with an up-
ward trend.6  In 1993 and 1994, there were about 16,000
jobs in the medical device industry. During the national
and regional slowdown in 1995, employment declined to
15,500. In 1997, it rose sharply and has since been in the
17,000 to 17,500 range. The strength of the industry is
apparent when compared with overall trends in Massachu-
setts manufacturing employment. In 1997, aggregate manu-
facturing employment rose, but it didn’t keep up with medi-
cal instruments.
Between January 1997 and June 1998, the date of the
most recent peak in statewide manufacturing employment,
total manufacturing jobs expanded by 2.4 percent, whereas
medical device jobs increased 9.1 percent. Then the effects
of the Asian financial crisis were felt. Statewide manufac-
turing employment fell sharply through June 1999 and has
remained roughly level since then. In June 2000, overall
manufacturing employment was 2.9 percent below its June
1998 peak. The fall in medical device employment, how-
ever, was less severe. As of June 2000, employment was
only 1.8 percent lower than in June 1998.
Medical device employment trends in Massachusetts
and in the United States were similar from 1997 to 1999.
Annual average employment grew by 2.6 percent in Massa-
chusetts and by 3.0 percent in the nation as a whole.
 Exports. In Massachusetts, the growth in medical de-
vice exports to foreign countries has been rapid. Europe
has been the chief destination of exports, with demand
driven by high incomes relative to most of the rest of the
world, but growth in East Asia is accelerating from a much
smaller per capita base. As incomes rise in East Asia in the
long run, the market should expand dramatically.






















Source: U.S. Department of Commerce
Massachusetts Employment Indices























































































Venture capital. By financing the development of new
technologies in start-up firms, venture capital funding plays
a crucial role in the growth of the medical device industry.
In the four-quarter period ending in September 2000, Mas-
sachusetts firms received a total of $314 million in venture
capital financing.7
The medical device sector competes with other technol-
ogy-related sectors for venture capital funding, principally
information technology (IT) and biotechnology. The total
supply of venture capital funds depends in part on investors’
perceptions of the likelihood of successful “liquidity events,”
such as initial public offerings (IPOs) or acquisitions in which
investors recoup their initial outlay plus a substantial profit.
Nationally, the medical device industry received 2.3 per-
cent of all venture capital funding in the four-quarter pe-
riod ending in September 2000. The share of all venture
capital funds going to medical device companies is roughly
equivalent to that received by biotechnology firms, but well
below that received by firms in the IT sector. The relative
unattractiveness of medical device companies compared with
IT is largely due to the longer time to a liquidity event,
especially an IPO outcome; FDA approval to market a de-
vice, and Health Care and Financing Administration
(HCFA) reimbursement approval needed to make the de-
vice profitable are time-consuming processes. The medical
device industry compares favorably with biotechnology on
this score, especially if a device can be registered with the
FDA as a 510(k) device, which can usually be brought to
market quickly, without the need for clinical trials.
Massachusetts receives roughly 10 percent of the total
supply of venture capital funds for medical devices in the
United States, though the amount can vary markedly in
the short run. For the four-quarter period ending in Sep-
tember 2000, the state re-
ceived 19.5 percent of all
U.S. venture capital fund-
ing for medical devices.
That figure is inflated by
the remarkably successful
first quarter of 2000, when
Massachusetts medical de-
vice companies received
$163.3 million, nearly half
of the U.S. total. In the
next two quarters, Massa-
chusetts companies re-
ceived $30.9 million and $46.2 million, representing 9.2
percent and 8.7 percent of the U.S. total.
In the amount of venture capital funding it receives,
how does Massachusetts fare relative to other areas? In terms
of the share of national venture capital financing, the state
does well. Its share of national venture capital funding for
medical devices (roughly 10 percent) exceeds what would
be expected, based on medical device industry measures,
such as the share of national shipments, value added, or
employment of 6 to 7 percent. On the other hand, venture
capital funding is concentrated in a handful of regions, in-
cluding Silicon Valley, New England, San Diego, the Mid-
west, and the Southeast. Though New England and Mas-
sachusetts typically rank
second or third, Massachu-
setts falls far behind Silicon
Valley in the share of funds
it receives.
The Role of Hospitals
and Universities
Teaching hospitals and uni-
versities play an arguably
more important role in the
growth of the medical device
sector than venture capital
does.8  More research is done in these institutions than in pri-
vate industry, often resulting in the licensing of technology to
medical device firms and occasionally in the formation of start-
up companies or joint ventures with existing companies. Mas-
sachusetts hospitals and universities license and form ventures
with companies around the world, but roughly 30 percent to
40 percent of the deals are with in-state partners.
Massachusetts public policy should focus
on providing quality public education,
lowering the cost of living, promoting
Massachusetts as a place to do business,
and developing an information-sharing













The competition for venture capitalfunds is, in part, affected by the sizeand risk of the expected return. By
their nature, venture capital investments are
risky. The expectation is that many—if not
most—ventures will fail to be profitable, but
those that are will compensate. Relative to bio-
technology, medical devices are perceived to
be less risky, but successes are perceived to be
less profitable.
The risk advantage derives from the small prob-
ability, in pharmaceuticals, of discovering a safe
and effective drug relative to the probability,
in medical devices, of developing a safe and ef-
fective instrument. On the other hand, the pay-
off for a successful drug is enormous relative
to the payoff for a successful device, because
once the drug or device is approved for mar-
keting, the marginal costs of producing a drug
are typically very small relative to those of pro-
ducing a medical device.






























































































Though aggregate figures for the effect on the medical
device industry are not available, the order of magnitude
can be inferred from a couple of examples. The University
of Massachusetts receives approximately $200 million in
research money annually, more than half of which goes to
the UMass Medical Center. The university’s Office of Com-
mercial Ventures and Intellectual Property had license rev-
enues of $12.4 million in FY 2001. Such revenues have
been rising at double-digit rates annually since the office
was started in 1995. Roughly three-quarters of these rev-
enues are medical related, and more than 10 percent are
due directly to medical devices.
Universities attribute the rapid growth in the licensing
of sponsored research to the Bayh-Dole Act, passed in the
1980s. This legislation allows universities to own the intel-
lectual property created by faculty and research personnel.
Other countries are beginning to emulate this model, an
indication of the policy’s success in increasing the volume
of university-sponsored research.
In another example, Massachusetts General Hospital
conducts $250 million in research annually, with a significant
portion related to medical device research in lasers, imaging
devices, and other radiology applications. Much of this re-
search is performed in the hospital’s Center for Minimally
Invasive Technologies. Medical device-related licensing rev-
enues are running at about $2 million per year. The role of
such research in other teaching hospitals is similar, though the
scale is less than at Mass General or Brigham and Women’s.
These two rank first and second, respectively, in the volume of
research performed by Massachusetts hospitals.
Conclusion
Massachusetts medical devices form the largest part of the
state’s vibrant medical science sector, which also includes
pharmaceuticals and biotechnology. Massachusetts is one
of the leading states in the production of medical devices,
providing good jobs that employ high-paid scientists, engi-
neers, and production workers. Through its economic links
with electronics, metal and plastics manufacturers, hospi-
tals, and financial institutions, the medical device sector com-
prises an important part of the state’s high-technology eco-
nomic base.
The long-term outlook for the sector is one of contin-
ued growth, supported by growing worldwide demand for
health services, and the state’s comparative advantage in
the development of new technologies. In order to ensure
the future success of the medical device sector—and the
state’s economy as a whole—Massachusetts public policy
should focus on providing quality public education, lower-
ing the cost of living (especially housing costs), promoting
Massachusetts as a place to do business, and developing an
information-sharing liaison with the industry.
1 Department of Commerce, 2000
2 For each criterion, first place was assigned five points; second four points;
and so on through one point for fifth place.
3 According to the Regional Economic Models Inc.’s Massachusetts eco-
nomic accounts for 1998, exports of the medical device industry (SICs
384 and 385) were estimated to be 1,441 million ($92) and output was
estimated to be 2,784 million ($92), for an export-to-output ratio of .5176.
Here, exports refer to sales to the rest of the United States and the world.
4 PriceWaterhouseCoopers, 2000
5 Annual wages are calculated as follows: For each sample individual, the
CPS reports earnings in the prior year from the primary employer (i.e.,
the employer for whom the individual worked the longest in the prior
year), as well as weeks worked last year and number of employers in the
prior year. (If the person worked for two or more employers concurrently,
only one employer is counted.) For purposes of calculating annual wages,
the sample was restricted to those individuals who worked for a single
employer in the prior year. Annual earnings were calculated as earnings
received from the primary employer divided by weeks worked times 52.
6 The sources of information for this section are the state and national
data from the “covered” payroll employment series, ES-202 (Division of
Employment and Training, 1993–2001, and the U.S. Bureau of Labor
Statistics, 2001). The ES-202 provides a time series of employment and
wages from 1993 to 1999 for Massachusetts and from 1997 to 1999 for
the United States as a whole for the medical device sector, defined as SICs
384 and 385.
7 The data on venture capital in this section are from quarterly surveys on
venture capital investments (PriceWaterhouseCoopers, 2000).
8 The sources of information for this section are interviews with execu-
tives from medical device companies or related businesses.
ALAN CLAYTON-MATTHEWS is an assistant professor and the director of quan-
titative methods in the Public Policy Program at the University of Massa-
chusetts Boston. He is also president of the New England Economic Project.
